Featured/ RLYB/ 06/01/2026 · 9:29 AM Avenzo Goes Public: $215 Million Merger with Rallybio to Fight Cancer Rallybio merges with Avenzo to boost cancer drug development; new AVZO company gets $215M funding and Nasdaq listing.
